Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

POZEN Inc.

POZNNASDAQ
Healthcare
Medical - Pharmaceuticals
$5.94
$-0.41(-6.90%)
U.S. Market opens in 17h 17m

POZEN Inc. Fundamental Analysis

POZEN Inc. (POZN) shows strong financial fundamentals with a PE ratio of 9.47, profit margin of 60.74%, and ROE of 60.98%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE60.98%
Operating Margin60.74%
PEG Ratio0.09
Current Ratio13.32

Areas of Concern

No major concerns flagged.
We analyze POZN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 56.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
56.3/100

We analyze POZN's fundamental strength across five key dimensions:

Efficiency Score

Excellent

POZN demonstrates superior asset utilization.

ROA > 10%
39.00%

Valuation Score

Excellent

POZN trades at attractive valuation levels.

PE < 25
9.47
PEG Ratio < 2
0.09

Growth Score

Weak

POZN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

POZN shows balanced financial health with some risks.

Debt/Equity < 1
5.43
Current Ratio > 1
13.32

Profitability Score

Moderate

POZN maintains healthy but balanced margins.

ROE > 15%
60.98%
Net Margin ≥ 15%
60.74%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is POZN Expensive or Cheap?

P/E Ratio

POZN trades at 9.47 times earnings. This suggests potential undervaluation.

9.47

PEG Ratio

When adjusting for growth, POZN's PEG of 0.09 indicates potential undervaluation.

0.09

Price to Book

The market values POZEN Inc. at 3.99 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.99

EV/EBITDA

Enterprise value stands at -10.82 times EBITDA. This is generally considered low.

-10.82

How Well Does POZN Make Money?

Net Profit Margin

For every $100 in sales, POZEN Inc. keeps $60.74 as profit after all expenses.

60.74%

Operating Margin

Core operations generate 60.74 in profit for every $100 in revenue, before interest and taxes.

60.74%

ROE

Management delivers $60.98 in profit for every $100 of shareholder equity.

60.98%

ROA

POZEN Inc. generates $39.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

39.00%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

9.47

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.99

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

5.43

vs 25 benchmark

Current Ratio

Current assets to current liabilities

13.32

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.61

vs 25 benchmark

ROA

Return on assets percentage

0.39

vs 25 benchmark

ROCE

Return on capital employed

0.42

vs 25 benchmark

How POZN Stacks Against Its Sector Peers

MetricPOZN ValueSector AveragePerformance
P/E Ratio9.4729.43 Better (Cheaper)
ROE60.98%800.00% Weak
Net Margin60.74%-20145.00% (disorted) Strong
Debt/Equity5.430.30 Weak (High Leverage)
Current Ratio13.324.64 Strong Liquidity
ROA39.00%-17936.00% (disorted) Strong

POZN outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews POZEN Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ